AGE Reader

Non-invasive cardiovascular risk assessment

Patient friendly diagnosis, Personalized care & Preventing disease

Wish to receive a quotation on product purchasing or leasing? Quotation request

Key publications

The AGE Reader has been validated in over 300 peer-reviewed publications. Please find below a selection of key publications for the different indications of the AGE Reader. 

Kidney disease:

Diabetes:

Cardiovascular disease:

Surgery patients:

General population:

Interested in receiving a white paper and product brochure? Please leave your name and email here.

More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

The AGE Reader App!
The new AGE Reader App allows you to generate a comprehensive Cardiovascular Risk Report based on the AGE Reader measurement. For each patient all visits can be documented and consulted in the easy to use App.
Read more »
About the company

More information about Diagnoptics.

Information for patients

Information on Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.